Symbols

SEER

Seer·NASDAQ

--(--)

SEER fundamentals

SEER Q4 2025 Earnings

Seer (SEER) released its earnings on Feb 26, 2026: revenue was 4.20M (YoY +5.03%), missed estimates; EPS was -0.29 (YoY +21.62%), beat estimates.

Revenue / YoY

4.20M

+5.03%

EPS / YoY

-0.29

+21.62%

Report date

Feb 26, 2026

SEER Earnings Call Summary for Q4,2025

Revenue resilience: 17% YoY growth to $16.6 million despite NIH funding delays, driven by 69% kit volume growth.
Strategic momentum: 82 instruments installed (67% YoY), PrognomIQ LDT launch validates clinical utility, $241M cash balance provides runway.
2026 outlook: Conservative $16-18M guidance reflects macro uncertainty, but 70 publications and 20,000-sample studies position for upside.
Shareholder returns: $25M new repurchase authorization adds to existing $25M program (13% shares retired to date).

Earnings

EPS

Revenue

Revenue & Expenses

SEER has released its 2025 Q4 earnings report, with revenue of 4.20M, reflecting a YoY change of 5.03%, and net profit of -15.99M, showing a YoY change of 26.44%. The Sankey diagram below clearly presents SEER's revenue sources and cost distribution.

Key Indicators

Seer (SEER) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Seer (SEER)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Seer (SEER)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Seer (SEER)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown